Novanta Announces Financial Results for the First Quarter 2024
First Quarter 2024 GAAP Revenue of $231 million First Quarter 2024 GAAP Net Income of $15 million First Quarter 2024...
Month: May 2024
Neumora Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
On-track to report topline Phase 3 data from KOASTAL-1 study with navacaprant in MDD; guidance narrowed to fourth quarter of...
Madrigal Pharmaceuticals Reports First-Quarter 2024 Financial Results and Provides Corporate Updates
CONSHOHOCKEN, Pa., May 07, 2024 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics...
Ionis reports first quarter 2024 financial results
WAINUATM launch on track; EU and Canada approval decisions expected this year Olezarsen NDA submitted to FDA for FCS; preparing EU...
Harvard Bioscience Announces First Quarter 2024 Financial Results
HOLLISTON, Mass., May 07, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced financial results for...
GlobalFoundries Reports First Quarter 2024 Financial Results
MALTA, N.Y., May 07, 2024 (GLOBE NEWSWIRE) -- GlobalFoundries Inc. (GF) (Nasdaq: GFS) today announced preliminary financial results for the...
First Watch Restaurant Group, Inc. Reports Strong Q1 2024 Financial Results
Total revenues increased 14.7%; same-restaurant sales growth of 0.5%*Income from operations margin of 5.1% and restaurant level operating profit margin...
Fusion Pharmaceuticals Reports First Quarter 2024 Financial Results and Announces Clinical Program Updates
Presented interim data from TATCIST trial of FPI-2265 in mCRPC at the 2024 American Association for Cancer Research (AACR) Annual...
FibroGen to Participate in Upcoming Investor Conferences
SAN FRANCISCO, May 07, 2024 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced that the company’s management will participate in...
Enanta Pharmaceuticals to Participate at the JMP Securities Life Sciences Conference
Contacts Media and Investors Contact: Jennifer Viera jviera@enanta.com Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small...
Dorman Products, Inc. Reports First Quarter 2024 Results
Highlights (All comparisons are to the prior year period unless otherwise noted):COLMAR, Pa., May 07, 2024 (GLOBE NEWSWIRE) -- Dorman...
Cronos Enters United Kingdom Cannabis Market
TORONTO, May 07, 2024 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) announced today...
Cipher Mining Provides First Quarter 2024 Business Update
First Quarter 2024 GAAP Net Income of $40m, and Non-GAAP Adjusted Earnings of $63mFirst Quarter 2024 Revenues of $48mCurrent Self-Mining...
Cipher Mining Provides First Quarter 2024 Business Update
First Quarter 2024 GAAP Net Income of $40m, and Non-GAAP Adjusted Earnings of $63mFirst Quarter 2024 Revenues of $48mCurrent Self-Mining...
Adicet Bio to Participate in a Fireside Chat at the Citizens JMP Life Sciences Conference
Contacts Adicet Bio., Inc. Investor and Media Contacts Anne Bowdidge abowdidge@adicetbio.com Janhavi Mohite Stern Investor Relations, Inc. 212-362-1200 janhavi.mohite@sternir.com Adicet...
AWH ANNOUNCES Q1 2024 FINANCIAL RESULTS
Achieved $142.4M Net Revenue in Q1 2024, a 25% Increase Year-Over-Year and 2% Increase Quarter-Over-Quarter Reported $32.5 million in Adjusted EBITDA,...
Ascot Announces C$5.0 Million Non-Brokered Flow Through Private Placement
VANCOUVER, British Columbia, May 07, 2024 (GLOBE NEWSWIRE) -- Ascot Resources Ltd. (TSX: AOT; OTCQX: AOTVF) (“Ascot” or the “Company”)...
Numinus Wellness Focused on Boosting Profitability and Expanding Community Support
VANCOUVER, BC, May 7, 2024 /PRNewswire/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF), a leader...
Solaris Provides Update on Warintza Operations, Optimization Progress, and Appointment of Leading Consultants for the EIA and PFS
VANCOUVER, British Columbia, May 07, 2024 (GLOBE NEWSWIRE) -- Solaris Resources Inc. (TSX: SLS; NYSE: SLSR) (“Solaris” or the “Company”)...
Sierra Metals Announces an Updated NI 43-101 Mineral Reserve and Resource Estimates for its Yauricocha and Bolivar Mines
Yauricocha Life-of-Mine (“LOM”)1,2 Over 8-year LOM with 10.4 million tonnes of Measured & Indicated Resources, over 10-year LOM with 13.2...
RLAB: M2MMA Unveils Spectacular Event M2MMA2: The Brouhaha by the Bay
DUBAI, UNITED ARAB EMIRATES / ACCESSWIRE / May 7, 2024 / Real American Capital Corp (RLAB), trading as M2MMA, the...
SOPHiA GENETICS Reports First Quarter 2024 Results
BOSTON and ROLLE, Switzerland, May 07, 2024 (GLOBE NEWSWIRE) -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and leader...
Descartes’ Annual Ecommerce Study Shows Online Buying Grows but 67% of Consumers Face Delivery Problems
ATLANTA and LONDON, May 07, 2024 (GLOBE NEWSWIRE) -- Descartes Systems Group (Nasdaq: DSGX) (TSX:DSG), the global leader in uniting...
Design Therapeutics to Participate in the 2024 RBC Capital Markets Global Healthcare Conference
CARLSBAD, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- Design Therapeutics, Inc. (Nasdaq: DSGN), a biotechnology company developing treatments for serious...
Connect Biopharma to Present a Late-Breaking Abstract at the American Thoracic Society (ATS) 2024 International Conference on the Positive Results from the Global Phase 2b Trial of Rademikibart in Patients with Moderate-to-Severe Asthma
SAN DIEGO, CA and TAICANG, China, May 07, 2024 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (“Connect Biopharma”...
Cellectar Biosciences to Announce First Quarter Financial Results and Host a Conference Call on Tuesday, May 14, 2024
FLORHAM PARK, N.J., May 07, 2024 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused...
Cheer Holding’s Subsidiary Obtained Recognition as Specialized and Innovative Enterprise in Beijing
BEIJING, May 07, 2024 (GLOBE NEWSWIRE) -- Cheer Holding, Inc. (NASDAQ: CHR) ("Cheer Holding," or the "Company"), a technology-driven leading...
Bloomin’ Brands CEO David Deno Retiring
Board of Directors Leading Search for Successor Contacts Cathie Koch Group Vice President, Corporate Affairs (813) 830-5127 Bloomin’ Brands, Inc....
Beam Therapeutics Reports Pipeline Updates and First Quarter 2024 Financial Results
Dosing Completed for Sentinel Cohort of BEACON Phase 1/2 Trial of BEAM-101 in Severe Sickle Cell Disease; Expansion Cohort InitiatedClinical...
CLOUD DX Signs Multi-Year Contract with Provincial Health Authority
This agreement is the 4th Provincial Health Authority contract for Cloud DX remote patient monitoring (RPM) services, alongside Alberta, the...
VIAVI Introduces Industry’s Most Comprehensive Solution for Resilient Positioning, Navigation and Timing for Critical Infrastructure
Fugro AtomiChron® Timing Service Augments Resilience, Assurance, Precision and Availability on a Global Scale CHANDLER, Ariz., May 7, 2024 /PRNewswire/...
Trimble Announces 2024 B2W Customer Innovation Award Winners
Heavy civil contractors Bituminous Roadways, Gulf Operators and Sherwood Companies achieve ROI and performance improvements through their use of B2W...
Vivid Seats Delivers Strong First Quarter Results
CHICAGO, May 07, 2024 (GLOBE NEWSWIRE) -- Vivid Seats Inc. (NASDAQ: SEAT) (“Vivid Seats” or “we”), a leading marketplace that...
Vivid Seats Delivers Strong First Quarter Results
CHICAGO, May 07, 2024 (GLOBE NEWSWIRE) -- Vivid Seats Inc. (NASDAQ: SEAT) (“Vivid Seats” or “we”), a leading marketplace that...
Sage Therapeutics to Participate in Upcoming May Investor Conferences
Contacts Investor Ashley Kaplowitz 786-252-1419 ashley.kaplowitz@sagerx.com Media Matthew Henson 917-930-7147 matthew.henson@sagerx.com Sage Therapeutics, Inc. (NASDAQ: SAGE), a biopharmaceutical company leading...
Premier, Inc. Reports Fiscal-Year 2024 Third-Quarter Results
Reaffirming fiscal 2024 financial guidance ranges Executed $400 million accelerated share repurchase transaction Contacts Investor contact: Ben Krasinski Senior Director,...
MarketAxess Reports First Quarter 2024 Financial Results
Record Emerging Markets, Eurobonds and Municipal Bonds Quarterly Commission Revenue Contacts INVESTOR RELATIONS Stephen Davidson MarketAxess Holdings Inc. +1 212...
Cheer Holding’s Subsidiary Obtained Recognition as Specialized and Innovative Enterprise in Beijing
BEIJING, May 07, 2024 (GLOBE NEWSWIRE) -- Cheer Holding, Inc. (NASDAQ: CHR) ("Cheer Holding," or the "Company"), a technology-driven leading...
Biodesix to Participate in the 2024 RBCCM Global Healthcare Conference
Contacts Media: Natalie St. Denis Natalie.StDenis@biodesix.com 1-720-925-9285 Investors: Chris Brinzey chris.brinzey@westwicke.com (339) 970-2843 Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic...
Aurinia Will Attend 2024 RBC Capital Markets Global Healthcare Conference
Contacts Media and Investor Inquiries: Andrea Christopher Corporate Communications and Investor Relations, Aurinia achristopher@auriniapharma.com ir@auriniapharma.com Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH)...